Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2010 1
2013 1
2014 2
2015 1
2016 1
2017 2
2019 1
2020 1
2021 1
2022 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study.
Hori H, Kudoh T, Nishimura S, Oda M, Yoshida M, Hara J, Tawa A, Usami I, Tanizawa A, Yumura-Yagi K, Kato K, Kobayashi R, Komada Y, Matsuo K, Horibe K; Japan Association of Childhood Leukemia Study. Hori H, et al. Int J Clin Oncol. 2017 Apr;22(2):387-396. doi: 10.1007/s10147-016-1062-1. Epub 2016 Nov 17. Int J Clin Oncol. 2017. PMID: 27858183 Clinical Trial.
Long-term Results of the Risk-adapted Treatment for Childhood B-Cell Acute Lymphoblastic Leukemia: Report From the Japan Association of Childhood Leukemia Study ALL-97 Trial.
Horibe K, Yumura-Yagi K, Kudoh T, Nishimura S, Oda M, Yoshida M, Komada Y, Hara J, Tawa A, Usami I, Tanizawa A, Kato K, Kobayashi R, Matsuo K, Hori H; Japan Association of Childhood Leukemia Study (JACLS), Japan. Horibe K, et al. J Pediatr Hematol Oncol. 2017 Mar;39(2):81-89. doi: 10.1097/MPH.0000000000000760. J Pediatr Hematol Oncol. 2017. PMID: 28169879 Clinical Trial.
Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol.
Suzuki N, Yumura-Yagi K, Yoshida M, Hara J, Nishimura S, Kudoh T, Tawa A, Usami I, Tanizawa A, Hori H, Ito Y, Miyaji R, Oda M, Kato K, Hamamoto K, Osugi Y, Hashii Y, Nakahata T, Horibe K; Japan Association of Childhood Leukemia Study (JACLS). Suzuki N, et al. Pediatr Blood Cancer. 2010 Jan;54(1):71-8. doi: 10.1002/pbc.22217. Pediatr Blood Cancer. 2010. PMID: 19813250
Outcome of TCF3-PBX1 positive pediatric acute lymphoblastic leukemia patients in Japan: a collaborative study of Japan Association of Childhood Leukemia Study (JACLS) and Children's Cancer and Leukemia Study Group (CCLSG).
Asai D, Imamura T, Yamashita Y, Suenobu S, Moriya-Saito A, Hasegawa D, Deguchi T, Hashii Y, Endo M, Hatakeyama N, Kawasaki H, Hori H, Horibe K, Yumura-Yagi K, Hara J, Watanabe A, Kikuta A, Oda M, Sato A; Japan Association of Childhood Leukemia Study (JACLS) & Children's Cancer and Leukemia Study Group (CCLSG). Asai D, et al. Cancer Med. 2014 Jun;3(3):623-31. doi: 10.1002/cam4.221. Epub 2014 Feb 28. Cancer Med. 2014. PMID: 24578304 Free PMC article.
Discontinuation of L-asparaginase and poor response to prednisolone are associated with poor outcome of ETV6-RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia.
Usami I, Imamura T, Takahashi Y, Suenobu SI, Hasegawa D, Hashii Y, Deguchi T, Hori T, Shimada A, Kato K, Ito E, Moriya-Saito A, Kawasaki H, Hori H, Yumura-Yagi K, Hara J, Sato A, Horibe K; Japan Association of Childhood Leukemia Study Group (JACLS). Usami I, et al. Int J Hematol. 2019 Apr;109(4):477-482. doi: 10.1007/s12185-019-02599-w. Epub 2019 Jan 28. Int J Hematol. 2019. PMID: 30689137
An overall characterization of pediatric acute lymphoblastic leukemia with CRLF2 overexpression.
Yano M, Imamura T, Asai D, Moriya-Saito A, Suenobu S, Hasegawa D, Deguchi T, Hashii Y, Kawasaki H, Hori H, Kosaka Y, Kato K, Horibe K, Yumura-Yagi K, Hara J, Matsumoto K, Kiyokawa N, Oda M, Sato A; Japan Association of Childhood Leukemia Study. Yano M, et al. Genes Chromosomes Cancer. 2014 Oct;53(10):815-23. doi: 10.1002/gcc.22190. Epub 2014 Jun 17. Genes Chromosomes Cancer. 2014. PMID: 24935070
Outcome after relapse in childhood acute lymphoblastic leukemia.
Yumura-Yagi K, Hara J, Horibe K, Tawa A, Komada Y, Oda M, Nishimura S, Yoshida M, Kudo T, Ueda K; Japan Association of Childhood Leukemia Study. Yumura-Yagi K, et al. Int J Hematol. 2002 Jul;76(1):61-8. doi: 10.1007/BF02982720. Int J Hematol. 2002. PMID: 12138898
The incidence of symptomatic osteonecrosis is similar between Japanese children and children in Western countries with acute lymphoblastic leukaemia treated with a Berlin-Frankfurt-Münster (BFM)95-based protocol.
Moriya K, Imamura T, Katayama S, Kaino A, Okamoto K, Yokoyama N, Uemura S, Kitazawa H, Sekimizu M, Hiramatsu H, Usami I, Ishida H, Hasegawa D, Hama A, Moriya-Saito A, Sato A, Sasahara Y, Suenobu S, Horibe K, Hara J; Japan Association of Childhood Leukemia Study Group (JACLS). Moriya K, et al. Br J Haematol. 2022 Mar;196(5):1257-1261. doi: 10.1111/bjh.17988. Epub 2021 Dec 8. Br J Haematol. 2022. PMID: 34879431
Protracted Administration of L-Asparaginase in Maintenance Phase Is the Risk Factor for Hyperglycemia in Older Patients with Pediatric Acute Lymphoblastic Leukemia.
Yoshida H, Imamura T, Saito AM, Takahashi Y, Suenobu S, Hasegawa D, Deguchi T, Hashii Y, Kawasaki H, Endo M, Hori H, Suzuki N, Kosaka Y, Kato K, Yumura-Yagi K, Hara J, Oda M, Sato A, Horibe K; Japan Association of Childhood Leukemia Study. Yoshida H, et al. PLoS One. 2015 Aug 28;10(8):e0136428. doi: 10.1371/journal.pone.0136428. eCollection 2015. PLoS One. 2015. PMID: 26317422 Free PMC article. Clinical Trial.
Risk-adjusted therapy for pediatric non-T cell ALL improves outcomes for standard risk patients: results of JACLS ALL-02.
Hasegawa D, Imamura T, Yumura-Yagi K, Takahashi Y, Usami I, Suenobu SI, Nishimura S, Suzuki N, Hashii Y, Deguchi T, Moriya-Saito A, Kato K, Kosaka Y, Hirayama M, Iguchi A, Kawasaki H, Hori H, Sato A, Kudoh T, Nakahata T, Oda M, Hara J, Horibe K; Japan Association of Childhood Leukemia Study Group (JACLS). Hasegawa D, et al. Blood Cancer J. 2020 Feb 27;10(2):23. doi: 10.1038/s41408-020-0287-4. Blood Cancer J. 2020. PMID: 32107374 Free PMC article. Clinical Trial.
11 results